Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Musculoskeletal pain, Myalgia
Clinical narrative: This spontaneous report as received from a approximately 65 years old female patient, reporting on herself. The patient's concurrent conditions included osteoporosis. It was stated that she was sensitive to medications because of her family history, her mother and father were sensitive to medications but not vaccines and she remembers her mother and father experiencing rashes, hives, redness and vomiting after taking unspecified medications. The patient's drug reactions and allergies included hives when taking an unspecified sulfa antibiotic and hives and rash after taking an unspecified antibiotic called "Micro-something" (consumer could not remember the name). On an unspecified date in 2017, the patient was vaccinated with a dose of ZOSTAVAX (strength, dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis. It was stated that the Lot number and expiration date of the sterile diluent (MERCK) used to reconstitute ZOSTAVAX were unknown by the consumer. On an unspecified date in March 2018, (reported as "sometime in the spring of 2018"), the patient was vaccinated with a dose of PNEUMOVAX 23 (strength, dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis. It was stated that the manufacturer and product brand name of the pneumococcal vaccine were unknown by the reporter, however, she thought it might have been PNEUMOVAX 23. On unknown dates, (reported as "few days after receiving each vaccine/after both vaccines"), the patient experienced identical adverse symptoms, which were: mild fever and chills that lasted for 3 to 4 days; swelling, redness and tenderness at the injection site, rash on chest and arms, hives around her jaw, muscle pain, itching and pain of the neck, skull and bottom of her spine, warmth of the face, shoulders hurt, pain of the jaw and pain in the mouth, therefore, on unknown dates (reported as "after each vaccination"), the patient had an office visit with her physician and both times she was placed under therapy treatment with PROZAC to treat her itching. Additionally, after each vaccine the patient visited her dentist because of the pain of her mouth and the dentist diagnosed her with burning mouth, the dentist prescribed an unspecified mouthwash both times which had to be compounded by the pharmacy and the consumer swished the medicine in her mouth to treat the pain in her mouth. Additionally, it was stated that the patient was not immunocompromised but her immune system was on the lower end. Additionally, it was stated that it is unclear if the patient fully recovered from her symptoms after receiving ZOSTAVAX (prior to receiving PNEUMOVAX 23). At the reporting time, the patient's current symptoms were warmth of her face, shoulders hurt, neck and skull itch, and pain and itching of the lower spine, the patient was under therapy treatment with unspecified antihistamines to treat her itching and it was stated that her physician recommended to visit an unspecified dermatologist because the consumer continued presenting itching. The outcome of the patient's chills, injection site swelling, injection site erythema, injection site pain, rash, pyrexia, myalgia, oral discomfort, pain in jaw, bone pain, neck pain and urticaria was reported as recovered. The reporter did not provide the causality assessment between the aforementioned events and therapy with ZOSTAVAX, PNEUMOVAX 23 or sterile diluent (MERCK).